BUSINESS Microbiotica Announces Positive Results from its Phase 1b Trial (MELODY-1) of MB097, a Precision Microbiome Co-Therapy in Advanced Melanoma Monday, May 18, 2026 · microbiotica Advertisement Read Original Article → Related Dispatches [EU] · Jul 4 Hospitality's real question isn't legal. It's cultural. [EU] · Jul 4 Tubidy Announces Continued Enhancements to Improve Digital Media Access for Users Worldwide [US] · Jul 4 Best Netflix True Crime Documentaries Based on Real Cases